About

We are economists and thinkers from a range of disciplines who challenge conventional wisdom and advance ideas to better serve society.

Research

We develop research that challenges economic orthodoxy and serves society.

Articles

Commentary, analysis, interviews, and research summaries by INET-affiliated writers.

Video

Interviews, presentations and video series with provocative economic thinkers, public figures and students.

Podcast

Economics and Beyond with Rob Johnson, a podcast featuring interviews with some of the world’s most important thinkers, artists, and activists about the pressing issues of our time. The podcast is also available on all major podcasting platforms, such as Apple, Spotify, Google, and Podbean.

Education

Video series and courses for students and educators interested in exploring new economic thinking.

Events

To foster new economic thinking, we host convenings that gather together a diverse community of thinkers from different fields, countries, and schools of thought.

YSI

Through the Young Scholars Initiative (YSI), INET provides support to students, young professionals, or others who embrace new and critical ways of thinking about the economy. YSI fosters conversation among those who wish to engage with new economic thinking and connects young scholars to the Institute’s vast network of economists.

Topics

Browse all INET content organized by topic

Zoë Folchman-Wagner

  • Lecturer, Natural and Applied Sciences Department at Bentley University

Zoë Folchman-Wagner, PhD is a Lecturer in the Natural and Applied Sciences Department at Bentley University. Zoë received a BS in Chemistry from New York University and a BE in Biomedical Engineering from Stevens Institute of Technology. She also has a MSE in Bioengineering from the University of Pennsylvania and a PhD in Pharmaceutical Sciences from the University of Southern California School of Pharmacy, where her dissertation explored the design and use of novel pH-response protein nanoparticles for targeted drug delivery to the tumor microenvironment. Her current research focuses on innovation systems for pharmaceuticals and assessments of pedagogical innovations, and she teaches courses on pharmacology, human biology, and the microbiome.

By this expert

Big Pharma Wants to Pocket the Profits From a COVID Treatment You Already Paid For

Article By Fred Ledley, Ekaterina Cleary, Zoë Folchman-Wagner, and Matthew Jackson | Jul 7, 2020

Gilead’s shareholders want exorbitant profits from Remdesivir, even though it was the public that enabled its development.